WithdrawnPhase 3

Epidural Dexamethasone for Labor Analgesia: the Effects on Ropivacaine Consumption and Labour Outcome

Stopped: French Agency for the Safety of Health Products refusal

0Started 2017-01

Plain-language summary

To assess the efficacy of epidural dexamethasone administration, compared to placebo, in reducing local anesthetics consumption during labor epidural analgesia in parturient women

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * First and single pregnancy, Full term (\> 37 wks amenorrhea), Cephalic presentation, Spontaneous labor, Epidural analgesia requested by the parturient Exclusion Criteria: * Minor patient, Planned cesarean section, Gestational hypertension and preeclampsia, Gestational diabetes, opioids or ocytocin administration before epidural analgesia preparation, Allergy to dexamethasone, Untreated gastroduodenal ulcer, epidural analgesia contraindications

What they're measuring

Hourly ropivacaine consumption expressed as mg/mL used during epidural analgesia in parturient women

Timeframe: From the beginning to the end of epidural analgesia, that could last up to 6 hours

Trial details

NCT IDNCT02857465

SponsorCentre Hospitalier Universitaire de la Réunion

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-06

View on ClinicalTrials.gov More Obstetric Pain trials